{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:58:56Z","timestamp":1792706336004,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13300-025-01800-0","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:47:17Z","timestamp":1759754837000},"page":"2227-2236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Automated Insulin Delivery System Therapy at Diagnosis on Metabolic Control in Children and Adolescents with Type\u00a01 Diabetes"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-5731","authenticated-orcid":false,"given":"Ugur Cem","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnay","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"\u00d6zalp K\u0131z\u0131lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samim","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damla","family":"G\u00f6k\u015fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"3","key":"1800_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type\u00a01 diabetes mellitus. Endocrinol Metab Clin N Am. 2010;39(3):481\u201397. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.011.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"14","key":"1800_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Genuth S, Lachin J, et al. Effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 2005;329(14):977\u201386. https:\/\/doi.org\/10.1056\/NEJM199309303291401.","journal-title":"N Engl J Med"},{"issue":"13","key":"1800_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type\u00a01 diabetes. JAMA. 2016;316(13):1407\u20138. https:\/\/doi.org\/10.1001\/jama.2016.11708.","journal-title":"JAMA"},{"issue":"10","key":"1800_CR4","doi-asserted-by":"publisher","first-page":"EVIDoa2400185","DOI":"10.1056\/EVIDoa2400185","volume":"3","author":"A Boucsein","year":"2024","unstructured":"Boucsein A, Nimri R, Bergenstal RM, et al. Automated insulin delivery for young people with type\u00a01 diabetes and elevated A1c. NEJM Evid. 2024;3(10):EVIDoa2400185. https:\/\/doi.org\/10.1056\/EVIDoa2400185.","journal-title":"NEJM Evid"},{"key":"1800_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000543034","author":"T Biester","year":"2024","unstructured":"Biester T, Berget C, Boughton C, et al. ISPAD clinical practice consensus guidelines 2024: diabetes technologies: insulin delivery. Hormone Res Paediatr. 2024. https:\/\/doi.org\/10.1159\/000543034.","journal-title":"Hormone Res Paediatr"},{"key":"1800_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308202","author":"YY Wang","year":"2024","unstructured":"Wang YY, Ying HM, Tian F, Qian XL, Zhou ZF. Three month use of hybrid closed-loop systems improves glycated hemoglobin levels in adolescents and children with type\u00a01 diabetes: a meta-analysis. PLoS ONE. 2024. https:\/\/doi.org\/10.1371\/journal.pone.0308202.","journal-title":"PLoS ONE"},{"issue":"1","key":"1800_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12902-022-00996-7","volume":"22","author":"G Petrovski","year":"2022","unstructured":"Petrovski G, Al Khalaf F, Campbell J, et al. Glycemic outcomes of advanced hybrid closed-loop system in children and adolescents with type\u00a01 diabetes previously treated with multiple daily injections. BMC Endocr Disord. 2022;22(1):80. https:\/\/doi.org\/10.1186\/s12902-022-00996-7.","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"1800_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15078","volume":"40","author":"TP Griffin","year":"2023","unstructured":"Griffin TP, Gallen G, Hartnell S, et al. UK Association of British Clinical Diabetologists' Diabetes Technology Network (ABCD-DTN): best practice guide for hybrid closed-loop therapy. Diabet Med. 2023;40(7):e15078. https:\/\/doi.org\/10.1111\/dme.15078.","journal-title":"Diabet Med"},{"issue":"2","key":"1800_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endrev\/bnac022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254\u201380. https:\/\/doi.org\/10.1210\/endrev\/bnac022.","journal-title":"Endocr Rev"},{"issue":"12","key":"1800_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jamapediatrics.2021.3965","volume":"175","author":"MB Abraham","year":"2021","unstructured":"Abraham MB, de Bock M, Smith GJ, et al. Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type\u00a01 diabetes: a randomized clinical trial. JAMA Pediatr. 2021;175(12):1227\u201335. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.3965.","journal-title":"JAMA Pediatr"},{"key":"1800_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.945678","author":"S Templer","year":"2022","unstructured":"Templer S. Closed-loop insulin delivery systems: past, present, and future directions. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.945678.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1800_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/dc20-2250","volume":"44","author":"OJ Collyns","year":"2021","unstructured":"Collyns OJ, Meier RA, Betts ZL, et al. Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type\u00a01 diabetes. Diabetes Care. 2021;44(4):969\u201375. https:\/\/doi.org\/10.2337\/dc20-2250.","journal-title":"Diabetes Care"},{"key":"1800_CR13","doi-asserted-by":"publisher","first-page":"1332418","DOI":"10.3389\/fendo.2024.1332418","volume":"15","author":"S Seget","year":"2024","unstructured":"Seget S, Chobot A, Tarasiewicz M, et al. Glycemic control in children with type\u00a01 diabetes treated with the advanced hybrid closed-loop system: a 2-year prospective, observational, two-center study. Front Endocrinol. 2024;15:1332418. https:\/\/doi.org\/10.3389\/fendo.2024.1332418.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1800_CR14","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.2337\/dc22-2046","volume":"46","author":"G Tornese","year":"2023","unstructured":"Tornese G, Carletti C, Lanzetta MA, et al. Safety of real-life usage of advanced hybrid closed-loop system Minimed 780G in children with type\u00a01 diabetes younger than 7\u00a0years old. Diabetes Care. 2023;46(6):e123\u20135. https:\/\/doi.org\/10.2337\/dc22-2046.","journal-title":"Diabetes Care"},{"issue":"10","key":"1800_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1056\/NEJMoa2203496","volume":"387","author":"CK Boughton","year":"2022","unstructured":"Boughton CK, Allen JM, Ware J, et al. Closed-loop therapy and preservation of C-peptide secretion in type\u00a01 diabetes. N Engl J Med. 2022;387(10):882\u201393. https:\/\/doi.org\/10.1056\/NEJMoa2203496.","journal-title":"N Engl J Med"},{"issue":"12","key":"1800_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jama.2023.2063","volume":"329","author":"J McVean","year":"2023","unstructured":"McVean J, Forlenza GP, Beck RW, et al. Effect of tight glycemic control on pancreatic beta-cell function in newly diagnosed pediatric type\u00a01 diabetes: a randomized clinical trial. JAMA. 2023;329(12):980\u20139. https:\/\/doi.org\/10.1001\/jama.2023.2063.","journal-title":"JAMA"},{"issue":"8","key":"1800_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2337\/dc24-0360","volume":"47","author":"J Ware","year":"2024","unstructured":"Ware J, Boughton CK, Allen JM, et al. Effect of 48\u00a0months of closed-loop insulin delivery on residual C-peptide secretion and glycemic control in newly diagnosed youth with type\u00a01 diabetes: a randomized trial. Diabetes Care. 2024;47(8):1441\u20138. https:\/\/doi.org\/10.2337\/dc24-0360.","journal-title":"Diabetes Care"},{"issue":"7","key":"1800_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/dia.2019.0026","volume":"21","author":"SR Patton","year":"2019","unstructured":"Patton SR, Noser AE, Youngkin EM, Majidi S, Clements MA. Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type\u00a01 diabetes mellitus. Diabetes Technol Ther. 2019;21(7):379\u201384. https:\/\/doi.org\/10.1089\/dia.2019.0026.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1800_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2022.0421","volume":"25","author":"SK Garg","year":"2023","unstructured":"Garg SK, Grunberger G, Weinstock R, et al. Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. Diabetes Technol Ther. 2023;25(1):1\u201312. https:\/\/doi.org\/10.1089\/dia.2022.0421.","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"1800_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/17434440.2024.2406901","volume":"21","author":"N Kadiyala","year":"2024","unstructured":"Kadiyala N, Hovorka R, Boughton CK. Closed-loop systems: recent advancements and lived experiences. Expert Rev Med Devices. 2024;21(10):927\u201341. https:\/\/doi.org\/10.1080\/17434440.2024.2406901.","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"1800_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/bmjdrc-2021-002537","volume":"15","author":"TJ Dos Santos","year":"2021","unstructured":"Dos Santos TJ, Dave C, MacLeish S, Wood JR. Diabetes technology use in children and adolescents with type\u00a01 diabetes: International survey results from the T1D Exchange, SWEET, and DPV registries. J Diabetes Sci Technol. 2021;15(6):1111\u20137. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002537.","journal-title":"J Diabetes Sci Technol"},{"key":"1800_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109877","volume":"190","author":"B Kimbell","year":"2022","unstructured":"Kimbell B, Rankin D, Elliott J, Gayle C, Lawton J. Parents\u2019 experiences of using a hybrid closed-loop system to manage their young child\u2019s type\u00a01 diabetes: qualitative study. Diabetes Res Clin Pract. 2022;190:109991. https:\/\/doi.org\/10.1016\/j.diabres.2022.109877.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"1800_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/pedi.13408","volume":"23","author":"JW Gregory","year":"2022","unstructured":"Gregory JW, Cameron FJ, Joshi K, et al. ISPAD clinical practice consensus guidelines 2022: diabetes in adolescence. Pediatr Diabetes. 2022;23(7):857\u201371. https:\/\/doi.org\/10.1111\/pedi.13408.","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 1","key":"1800_CR24","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.2337\/dc24-S014","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 14. Children and adolescents: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S258\u201381. https:\/\/doi.org\/10.2337\/dc24-S014.","journal-title":"Diabetes Care"},{"key":"1800_CR25","doi-asserted-by":"publisher","first-page":"117955142312067","DOI":"10.1177\/11795514231206730","volume":"16","author":"A Khadilkar","year":"2023","unstructured":"Khadilkar A, Oza C, Mondkar SA. Insulin resistance in adolescents and youth with type\u00a01 diabetes: a review of problems and solutions. Clin Med Insights Endocrinol Diabetes. 2023;16:11795514231206730. https:\/\/doi.org\/10.1177\/11795514231206730.","journal-title":"Clin Med Insights Endocrinol Diabetes"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:09:46Z","timestamp":1761948586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1800"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01800-0","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"U\u011fur Cem Y\u0131lmaz, Deniz \u00d6zalp K\u0131z\u0131lay, G\u00fcnay Demir, Samim \u00d6zen, and Damla G\u00f6k\u015fen have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All data used in this study were retrospectively obtained from patient records, ensuring confidentiality through anonymization. Informed consent was obtained from all participants or their legal guardians for the use of anonymized clinical data in research. The study was conducted in accordance with the Declaration of Helsinki (revised October 2013). Ethical approval was obtained from the university ethics committee (approval number 25-2T\/48).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}